Navigation Links
Mount Sinai Grants Exclusive License to Plexcera Therapeutics to Develop Treatments for Farber Disease and Cystic Fibrosis
Date:9/11/2013

D, from the Center for Medical Biotech at the University of Duisburg-Essen, Germany, who will serve on Plexcera’s Scientific Advisory Board. Dr. Schuchman has extensive research and development experience with these disorders and enzyme replacement therapy specifically. Dr. Gulbins has identified a central role for excess ceramide accumulation in cystic fibrosis, as well as other pulmonary diseases.

“Mount Sinai has a strong track record of developing breakthrough products for rare diseases. Dr. Schuchman has worked with key scientific, clinical and industry thought leaders for many years and can call on their expertise and commitment,” said Mr. Galanin, CEO of Plexcera. “The collaboration with QOL Medical gives us access to key infrastructure components such as clinical, regulatory and manufacturing expertise.”

As part of the license, Mount Sinai received equity in the new company, as well as royalties. This is the second major license agreement negotiated this year by MSIP in the field of orphan diseases, both originating from research conducted by the Department of Genetic and Genomic Sciences.

About Mount Sinai Innovation Partners
Mount Sinai Innovation Partners (MSIP), part of the Icahn School of Medicine at Mount Sinai, facilitates the transfer of discovery from the laboratory to the marketplace, acting as the interface with commercial entities.

MSIP is responsible for the full spectrum of commercialization activities required to bring the Icahn School of Medicine’s inventions to life. These activities include evaluating, patenting, marketing, and licensing new technologies, while also negotiating agreements for sponsored research, material transfer, and confidentiality. For more information on MSIP, visit: http://www.mountsinai.org/innovation

About Plexcera Therapeutics, LLC
Plexcera Therapeutics was f
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. GranuFlo Lawsuits Mount, as Bernstein Liebhard LLP Notes New Consolidated Litigation for GranuFlo Recall Claims Filed in Massachusetts State Court
2. Mount Sinai Receives NIH Grant to Increase the Engagement of African Americans in Colorectal Cancer Screening
3. Janina A. Longtine, MD of the Icahn School of Medicine at Mount Sinai Elected President of the Association for Molecular Pathology
4. Mount Sinai receives NIH grant to increase colorectal cancer screenings in African Americans
5. GranuFlo Lawsuit News: Bernstein Liebhard LLP Comments on Fresenius FDA Warning Letter, as GranuFlo Recall Claims Mount
6. Mount Sinai Experts Share Tips for Ovarian Cancer Awareness Month in September
7. Researchers from Mount Sinai receive NIH grant to study promising treatment for Autism subtype
8. Music for Relaxation
9. “Sculptations” Helps People Create Enormous Amounts of Money to Live a Life of Comfort and Happiness – V kool
10. Mount Sinai and Exosome Partner to Accelerate Translation of Body Fluid Molecular Diagnostics to Overcome Limitations of Tissue Biopsy in Areas of Unmet Medical Needs
11. Amerinet and NML Collaborate with Intermountain Healthcare on Integrated Supply Chain Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... 01, 2015 , ... “ reTXT ” was featured on NewsWatch as part ... on the market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch ... clarify, edit and delete any message including ones already sent. , While text messaging ...
(Date:7/31/2015)... Vegas, NV (PRWEB) , ... July 31, 2015 , ... Ticket Down is a reputable ... Vegas at the MGM Grand Garden Arena. Fans of every genre of music will ... Friday, September 18th, the first day of the festival, the following artists will perform: ...
(Date:7/31/2015)... Clara, CA (PRWEB) , ... August 01, 2015 , ... Super Bowl 50 ... The National Football League’s biggest day each year is the Super Bowl. In the two ... that takes place from the host venue. The 2016 Super Bowl game will mark the ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... new industry players to know in predictive health analytics , Jvion continues ... technologies. The firm creates predictive software that targets patient and population level illness ...
(Date:7/31/2015)... ... ... Sculpted Contours Luxury Medical Aesthetics announces the arrival of the newest applicator ... new applicator in the United States as an upgrade to the CoolSmooth applicator cleared ... applicator required a 2 hour treatment time. The new CoolSmooth Pro reduces the ...
Breaking Medicine News(10 mins):Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3
... has asked the pharmaceutical companies to develop cheap and ... HIV in children’s living in African countries. The charity ... and affordable laboratory tests for detecting the virus antibodies ... ,There is a need to develop new laboratory ...
... the University of Frankfurt has revealed that singing protects ... the production of antibodies. Singing also serves to demonstrate ... many as 31 amateur singers were studied before these ... and walking in terms of its positive effects on ...
... international team of researchers has revealed that the inhalers ... chances of an attack.// Mathematical modeling techniques have been ... an asthma attack is likely to take place. The ... study. ,Silverman, professor of child health in the ...
... using stem cell therapy for restoring hearing loss in deaf ... ear and regenerating the cells for treatment. ,The ... sensory nerve cells and make them divide into required cell, ... the research in ear stem cell regeneration is in its ...
... in Europe and more so in Germany. Keeping with the trend ... which they claim has the power to calm the senses and ... and also contains lecithin soya extract, folic acid and vitamins. ... the sale of this beer is even better than aspirin, as ...
... study has revealed that a IQ level is directly linked ... blood is directly linked to the IQ level of the ... This study also reveals that the children who grow taller ... growth hormones are administered to the short children, then their ...
Cached Medicine News:Health News:Asthma Attacks May Be Triggered By Inhalers 2
(Date:7/31/2015)... India , July 31, 2015 ... CRM solutions for video, data and cloud computing ... with a leading pharma giant for Internet of ... different IoT applications offered on subscription model. ... Pharma giant is striving for business innovations ...
(Date:7/30/2015)... Calif. , July 30, 2015 IRIDEX ... will release its second quarter 2015 financial results after ...   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, ... the quarter and other business developments. Interested ...
(Date:7/30/2015)... you a special edition of #MedicareMonday on Medicare,s 50 th anniversary. As Medicare ... and continue highlighting the success of the prescription drug benefit, commonly referred to as ... latest infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3
... Takeda Global Research & Development Center, Inc., ... (FDA) has assigned a Prescription Drug User Fee Act ... review of its investigational type 2 diabetes therapy alogliptin, ... with pioglitazone in a single tablet.   ...
... its third annual Human Milk (breast milk) Collection Campaign in ... As part of the campaign, Medela will donate a total ... units across the country. "We want to do ... of human milk feeding -- to help protect premature babies ...
Cached Medicine Technology:Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone 2Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone 3Medela Announces Virtual Breast Milk Collection Campaign in Honor of Prematurity Awareness Month 2
300XL System, English (U.K. cord), 100-240 VAC....
Micro-mini fiber optic light....
Micro-mini fiber optic light....
The MC-3 allows for simultaneous use of two lamps, with an additional built-in spare....
Medicine Products: